AlphaValue upgrades Amplifon stock target to EUR 16.70

Published on 10/13/2026 at 13:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due on October 29, 2026. Amplifon stock costs EUR 12.66 on October 13, 2026 at 1:37 p.m. CEST, with a P/E of 41.70.

AlphaValue raised its Amplifon target from EUR 13.20 to EUR 16.70 and upgraded the rating on October 5, 2026.
Amplifon is scheduled to publish third-quarter 2026 results on October 29, 2026.
Amplifon stock was trading at EUR 12.66 at Lang & Schwarz on October 13, 2026 at 1:37 p.m. CEST.
Amplifon had a P/E ratio of 41.70 and market capitalization of EUR 2.8 billion as of October 13, 2026.

Editorial-Foto eines Trading-Floors mit Kurscharts und Healthcare-Sektorkürzel — Börsen-Editorial zeigt Trading-Floor mit Gesundheits-Charts, thematisch verknüpft mit Amplifon S.p.A., ISIN IT0004056880, FTSE MIB gelistet, Illustration mit AI erstellt.

AlphaValue upgraded Amplifon from Add to Buy and raised its price target from EUR 13.20 to EUR 16.70 on October 5, 2026, according to Oranfinanza. The new target is 31.94 percent above the Lang & Schwarz price of EUR 12.66, calculated in the same currency.

Results arrive October 29

Amplifon is scheduled to publish its third-quarter 2026 results on October 29, 2026. Rankia also reported that an extraordinary shareholders meeting is scheduled for the same date, with decisions linked to the planned GN Hearing transaction.

The date gives the market a defined checkpoint for the next operating update. AlphaValue cited stronger hearing-aid market conditions, better-than-expected second-quarter performance and continued momentum into the third quarter when it changed its rating and target.

First-half figures set the base

Amplifon generated EUR 1.1857 billion of revenue in the first half of 2026, up 1.30 percent at constant exchange rates. Adjusted EBITDA reached EUR 298.0 million in the same period, an increase of 3.60 percent from the prior year, while the adjusted EBITDA margin rose to 25.10 percent, according to Capital.com.

The combination of revenue growth and higher adjusted profitability matters for the October report because the second-quarter organic growth rate reached 4.70 percent. The next release will show whether that acceleration continued through the third quarter.

Price and valuation

Amplifon was trading at EUR 12.66 at Lang & Schwarz on October 13, 2026 at 1:37 p.m. CEST. The quote had a bid of EUR 12.65 and an ask of EUR 12.67, giving investors a narrow displayed spread of EUR 0.02.

The company had a market capitalization of EUR 2.8 billion and a P/E ratio of 41.70 as of October 13, 2026. The AlphaValue target of EUR 16.70 therefore stands EUR 4.04 above the euro price, while the scheduled results date remains the next clearly defined company event.

Comparison with peers

Amplifon: P/E 41.70, market capitalization EUR 2.8 billion
Demant A/S (Nasdaq Copenhagen, DKK): plus 1.94 percent, P/E 46.38, market capitalization DKK 75.4 billion
Sonova Holding AG (SIX Swiss Exchange, CHF): plus 0.52 percent, P/E 37.29, market capitalization CHF 16.0 billion

What matters next

Amplifon's October 29 results will put the first-half revenue growth of 1.30 percent and adjusted EBITDA growth of 3.60 percent into a new period context. The current valuation leaves the market focused on execution, margin development and the planned GN Hearing integration.

The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.